Revolution Medicines, Inc. (RVMD)
196.22
-3.93
(-1.96%)
USD |
NASDAQ |
Nov 10, 09:42
Revolution Medicines Cash and Short Term Investments (Quarterly) : 3.651B for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 3.651B |
| June 30, 2026 | 3.938B |
| March 31, 2026 | 1.908B |
| December 31, 2025 | 2.026B |
| September 30, 2025 | 1.932B |
| June 30, 2025 | 2.137B |
| March 31, 2025 | 2.103B |
| December 31, 2024 | 2.289B |
| September 30, 2024 | 1.549B |
| June 30, 2024 | 1.591B |
| March 31, 2024 | 1.704B |
| December 31, 2023 | 1.853B |
| September 30, 2023 | 813.20M |
| June 30, 2023 | 909.49M |
| March 31, 2023 | 909.80M |
| December 31, 2022 | 644.94M |
| Date | Value |
|---|---|
| September 30, 2022 | 655.01M |
| June 30, 2022 | 461.43M |
| March 31, 2022 | 518.75M |
| December 31, 2021 | 577.05M |
| September 30, 2021 | 608.66M |
| June 30, 2021 | 646.32M |
| March 31, 2021 | 681.59M |
| December 31, 2020 | 440.74M |
| September 30, 2020 | 466.14M |
| June 30, 2020 | 325.44M |
| March 31, 2020 | 347.95M |
| December 31, 2019 | 122.76M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 69.59M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Moderna, Inc. | 5.171B |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Intellia Therapeutics, Inc. | 474.11M |
| Twist Bioscience Corp. | 166.84M |